Delivery Order SPE2DB20D7066-SPE2DB25FC4HE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,687.77 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.04 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award carries no set-aside designation, indicating it was competitively awarded. Performance...
- The Defense Logistics Agency awarded a $1,496.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of June 9, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $1,579.61 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contraceptive pharmaceutical product will support federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.30 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This competitively awarded delivery order, issued on September 4, 2025, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $1,255.38. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,068.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on September 4, 2025, with completion expected by September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The etonogestrel-EE vaginal ring is a hormonal contraceptive product used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, with a ceiling value of $1,165.71. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,076.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of June 23, 2025. This non-set-aside contract represents a small-value delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, valued at $3,009.21. The delivery order, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4HEDelivery Order
The Defense Logistics Agency awarded a $1,345.05 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 11, 2025, with completion by August 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC encompasses a vast range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This specific delivery order for vaginal contraceptive rings reflects the company's role in supplying specialized pharmaceutical products to support the medical needs of the Defense Department's healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/11/25 |